ATP6V0D2 Antikörper (Middle Region)
-
- Target Alle ATP6V0D2 Antikörper anzeigen
- ATP6V0D2 (ATPase, H+ Transporting, Lysosomal 38kDa, V0 Subunit D2 (ATP6V0D2))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Human, Maus, Ratte, Kaninchen, Hund, Meerschweinchen, Rind (Kuh), Pferd, Schwein
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ATP6V0D2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- GLRLLAQAED FDQMKNVADH YGVYKPLFEA VGGSGGKTLE DVFYEREVQM
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 86%, Horse: 93%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 100%, Rat: 100%
- Produktmerkmale
- This is a rabbit polyclonal antibody against ATP6V0D2. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human ATP6V0D2
- Top Product
- Discover our top product ATP6V0D2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 350 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis." in: Cellular signalling, Vol. 26, Issue 11, pp. 2358-69, (2014) (PubMed).
: "Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion." in: The Journal of biological chemistry, Vol. 287, Issue 23, pp. 19229-41, (2012) (PubMed).
: "
-
Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis." in: Cellular signalling, Vol. 26, Issue 11, pp. 2358-69, (2014) (PubMed).
-
- Target
- ATP6V0D2 (ATPase, H+ Transporting, Lysosomal 38kDa, V0 Subunit D2 (ATP6V0D2))
- Andere Bezeichnung
- ATP6V0D2 (ATP6V0D2 Produkte)
- Synonyme
- ATP6D2 antikoerper, VMA6 antikoerper, AI324824 antikoerper, V-ATPase antikoerper, 1620401A02Rik antikoerper, ATPase H+ transporting V0 subunit d2 antikoerper, ATPase, H+ transporting, lysosomal V0 subunit D2 antikoerper, ATPase H+ transporting V0 subunit D2 antikoerper, ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 L homeolog antikoerper, ATP6V0D2 antikoerper, Atp6v0d2 antikoerper, atp6v0d2.L antikoerper
- Hintergrund
-
ATP6V0D2 is the subunit of the integral membrane V0 complex of vacuolar ATPase. Vacuolar ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells, thus providing most of the energy required for transport processes in the vacuolar system. ATP6V0D2 may play a role in coupling of proton transport and ATP hydrolysis.
Alias Symbols: ATP6D2, FLJ38708, VMA6
Protein Interaction Partner: AGO3, RBM15B, RPS3, NDUFB8, ADRM1,
Protein Size: 350 - Molekulargewicht
- 40 kDa
- Gen-ID
- 245972
- NCBI Accession
- NM_152565, NP_689778
- UniProt
- Q8N8Y2
- Pathways
- Transition Metal Ion Homeostasis, Proton Transport
-